Damon has more than 20 years of commercial life science and private investment experience. He has participated in five startups from early inception to exit. His commercial experience includes pharmaceuticals, biotechnology, healthcare analytics and medical devices, across a wide range of therapeutic categories. Damon has many years of experience working with early stage entrepreneurs. His expertise includes fund raising, executive management, sales, business development and strategic planning.
In 2015, Damon formed Kaliber Investments and is an owner in the fund. Kaliber Investments is a healthcare investment fund for accredited investors, with an emphasis on small to mid-cap pharmaceutical and biotechnology companies. Damon graduated from George Mason University in 1996 with a Bachelor of Science in biology and began his career in pharmaceuticals. Damon holds an MBA from Duke University’s Fuqua School of Business, the Certified Licensing Professional designation from the Licensing Executive Society and the FINRA Series 65. Damon serves on the board of directors of The Green Chair Project and is a member of the Advisory Board of both Trill Financial and Epicypher.